Shanghai Best-link Bioscience, Llc

This study is testing an experimental drug called BL0020 for patients whose non-small cell lung cancer has transformed into a more aggressive small cell type after previous treatment. The trial will enroll 48 adults to see if BL0020 can shrink tumors and control the cancer. Resea…

This early-stage study aims to understand the safety and how long a new injection called BL0175 stays in the blood of healthy postmenopausal women. Researchers will compare it to an existing drug called fulvestrant. The trial will enroll 27 participants who will receive one dose …